Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Baudax Bio (BXRX) stocks in Canada

Learn how to easily invest in Baudax Bio stocks.

Baudax Bio is a biotechnology business based in the US. Baudax Bio stocks (BXRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.6769 – a decrease of 2.68% over the previous week. Baudax Bio employs 57 staff and has a trailing 12-month revenue of around $756,000.

How to buy shares in Baudax Bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BXRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Baudax Bio stock price (NASDAQ:BXRX)

Use our graph to track the performance of BXRX stocks over time.

Baudax Bio shares at a glance

Information last updated 2022-01-17.
Latest market close$0.20
52-week range$0.19 - $2.12
50-day moving average $0.35
200-day moving average $0.64
Wall St. target price$1.83
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.05

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Baudax Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Baudax Bio price performance over time

Historical closes compared with the close of $0.1964 from 2022-01-19

1 week (2022-01-14) -2.68%
1 month (2021-12-21) -41.29%
3 months (2021-10-21) -64.22%
6 months (2021-07-21) -70.69%
1 year (2021-01-21) -87.49%
2 years (2020-01-21) -97.21%
3 years (2019-01-17) N/A
5 years (2017-01-17) N/A

Baudax Bio financials

Revenue TTM $756,000
Gross profit TTM $-1,239,000
Return on assets TTM -53.3%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $17.1 million

TTM: trailing 12 months

Baudax Bio share dividends

We're not expecting Baudax Bio to pay a dividend over the next 12 months.

Baudax Bio share price volatility

Over the last 12 months, Baudax Bio's shares have ranged in value from as little as $0.1915 up to $2.12. A popular way to gauge a stock's volatility is its "beta".

BXRX.US volatility(beta: 2)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Baudax Bio's is 2.0031. This would suggest that Baudax Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Baudax Bio overview

Baudax Bio, Inc. , a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site